Subscribe for the latest consumer trends, trade news, nutrition science and regulatory updates in the supplement industry!
Join 37,000+ members. Yes, it's completely free.
Prebiotin Tested in NIH/NIDDK Pilot Study with End Stage Renal Disease Patients
The NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) Hemodialysis Novel Therapies (HDNT) Study Group has been conducting early phase studies of novel interventions with the long-term goal to test promising therapies in full-scale clinical trials.
October 17, 2017
1 Min Read
The NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) Hemodialysis Novel Therapies (HDNT) Study Group has been conducting early phase studies of novel interventions with the long-term goal to test promising therapies in full-scale clinical trials.
You May Also Like